Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Alzamend Neuro Inc ALZN

Healthcare Biotechnology
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer’s, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other... see more

Current News (NDAQ:ALZN)

Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital

PR Newswire November 19, 2025

Alzamend Neuro to Present at the 2025 Military Health System Research Symposium

GlobeNewswire July 28, 2025

Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs

GlobeNewswire July 23, 2025

Alzamend Neuro Announces Final Closing of $5 Million Private Placement Months Ahead of Schedule

GlobeNewswire June 16, 2025

Alzamend Neuro Announces Dosing of First Patient in its Phase II Clinical Trial of AL001 "Lithium in Brain" Study Taking Place at Massachusetts General Hospital

GlobeNewswire May 29, 2025

Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 "Lithium in Brain" Study Taking Place at Massachusetts General Hospital

GlobeNewswire May 19, 2025

Alzamend Neuro Initiates First Phase II Clinical Trial of AL001 "Lithium in Brain" Study Taking Place at Massachusetts General Hospital

GlobeNewswire May 13, 2025

Alzamend Neuro Announces Reverse Stock Split

GlobeNewswire May 8, 2025

Alzamend Neuro Partners with QMENTA, to Advance AI-Powered Imaging for its Phase II Clinical Trial of AL001 Study to Take Place at Massachusetts General Hospital

GlobeNewswire May 7, 2025
View More News ››

Opinion & Analysis (NDAQ:ALZN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ALZN)

Using technical analysis for this stock.

It is signalling strength to the upside for shareholders today
coolfooldumbguy - June 3, 2025

Buy buddy buy.

So good luck to all of you guys out there
coolfooldumbguy - May 13, 2025

Here we go, excellent coverage!

https://youtu.be/Ci69nQCyuPw?si=VOLY7cJ6pneFoIzH
BryceCanada - May 13, 2025

RE:ALZN....Is it over.....early a.m rip over $10

Pardon me .....BAOS not INHD
Iseneschal - May 13, 2025

ALZN....Is it over.....early a.m rip over $10

now $6.50 EDGAR shows SEC Form 144 Sale of Securities Just like INHD yesterday
Iseneschal - May 13, 2025

ALZN.... On watch list this a.m....News Release

Alzamend Neuro Announces Completion of a Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five...
Iseneschal - February 19, 2025
View more Bullboard ››

North Peak Resources Ltd.

North Peak Resources Ltd.

North Peak Resources Ltd. operates as a gold exploration and development company. The company’s flagship project is the ...
View More »

Podcasts